Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrastructural changes in cryopreserved tracheal grafts of sprague-dawley rats.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2009
Same author

Facile synthesis of size-tunable micro-octahedra via metal-organic coordination.

Chemical communications (Cambridge, England)·2009
Same author

N-acetyl cysteine and penicillamine induce apoptosis via the ER stress response-signaling pathway.

Molecular carcinogenesis·2009
Same author

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs.

Breast cancer research and treatment·2009
Same author

N-glycosylation of ATF6beta is essential for its proteolytic cleavage and transcriptional repressor function to ATF6alpha.

Journal of cellular biochemistry·2009
Same author

A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo.

Cancer immunology, immunotherapy : CII·2009

Related Experiment Video

Updated: Apr 17, 2026

Culture of myeloid dendritic cells from bone marrow precursors
06:39

Culture of myeloid dendritic cells from bone marrow precursors

Published on: July 25, 2008

23.3K

Blastic plasmacytoid dendritic cell neoplasm: A case report.

Wei Wang1, Wensheng Li2, Jin-Jing Jia1

  • 1Department of Dermatology, Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, P.R. China.

Oncology Letters
|February 10, 2015
PubMed
Summary

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive lymphoma. This case highlights its rapid progression and poor prognosis, with mortality occurring within three months of presentation.

Keywords:
blastic plasmacytoid dendritic cell neoplasmcyclophosphamidediagnosisdoxorubicinprognosistreatmentvincristine and prednisolone chemotherapy

More Related Videos

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

13.1K
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

11.6K

Related Experiment Videos

Last Updated: Apr 17, 2026

Culture of myeloid dendritic cells from bone marrow precursors
06:39

Culture of myeloid dendritic cells from bone marrow precursors

Published on: July 25, 2008

23.3K
Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow
08:01

Fluorescence-activated Cell Sorting for Purification of Plasmacytoid Dendritic Cells from the Mouse Bone Marrow

Published on: November 4, 2016

13.1K
Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors
13:34

Assessing the Development of Murine Plasmacytoid Dendritic Cells in Peyer's Patches Using Adoptive Transfer of Hematopoietic Progenitors

Published on: March 17, 2014

11.6K

Area of Science:

  • Hematology
  • Oncology
  • Dermatology

Background:

  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy.
  • It is characterized by aggressive clinical behavior, cutaneous manifestations, and poor prognosis.

Purpose of the Study:

  • To report a case of stage IIIE BPDCN in a 54-year-old male.
  • To illustrate the rapid progression and poor prognosis associated with BPDCN.

Main Methods:

  • Diagnosis was confirmed through pathological and immunohistochemical analysis of abdominal skin lesion biopsies.
  • Treatment involved cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.

Main Results:

  • The patient presented with symptoms characteristic of BPDCN.
  • Despite chemotherapy, the patient succumbed to the disease nine days after its discontinuation.
  • The overall survival period from presentation to mortality was less than three months.

Conclusions:

  • BPDCN is an aggressive neoplasm with a rapid disease course.
  • This case underscores the challenges in managing BPDCN and its typically poor prognosis.